RxDoctor Payments Data

Aman Upadhyay, MD

Pain Medicine · Cleveland, OHNPI 1598920886

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (43.1%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 32 manufacturers reported payments, led by Boston Scientific at 59.1% of the total. Reporting peaked in 2024 at $11,455 and has fallen 93.6% since, to $733 in 2025. Among pain medicine clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$40,454in general payments, 2019–2025

Across 366 payments — averaging $110.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$24K
  • Nevro Corp.$5K
  • Medtronic$4K
  • Relievant Medsystems, Inc.$3K
  • Vertos Medical, Inc.$1K
  • Saluda Medical Americas, Inc.$943
  • plus $3K from 26 others

What the payments were for

  • Speaking & faculty fees$17,42543%
  • Travel & lodging$8,56621%
  • Food & beverage$14,46336%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$40,454 in reported general payments places this provider in the 95th percentile of 245 pain medicine providers in Ohio.

See all pain medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$490,265
Medicare patients
509
Services billed
3,887

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen1,163$26,491
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen689$18,527
Diclofenac Potassium15$14,084
MovantikNaloxegol Oxalate19$7,620
Pregabalin132$5,462
Oxycodone Hcl245$4,177
Gabapentin245$3,522
Acetaminophen-CodeineAcetaminophen With Codeine57$2,368
Nortriptyline Hcl201$2,003
Tizanidine Hcl263$1,939
Diclofenac Sodium162$1,918
Fentanyl19$1,624
Methocarbamol108$1,348
Morphine Sulfate ErMorphine Sulfate58$1,187
Cyclobenzaprine Hcl107$1,101

Paid to pharmacies, not to this prescriber.

Other pain medicine in Cleveland

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →